Priothera

PITCH

We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in these patients.

Based in

Dublin

Created in

> Website

LATEST INVESTMENT

#Healthtech 10.2020

Priothera

£26.8M

Fountain Healthcare Partners, HealthCap, Tekla Capital Management, LLC and EarlyBird Venture Capital